Early diagnostic value of high‐sensitivity cardiac troponin T for cancer treatment‐related cardiac dysfunction: a meta‐analysis
Abstract Early diagnosis of cancer treatment‐related cardiac dysfunction (CTRCD) is important as cancer therapy increases the risk of cardiac dysfunction. High‐sensitivity cardiac troponin T (hs‐cTnT) is a highly specific marker of myocardial injury. However, its diagnostic value for CTRCD has not b...
Main Authors: | Xinfang Lv, ChenLiang Pan, Huan Guo, Juan Chang, Xiang Gao, Xue Wu, Xiaodong Zhi, Chunzhen Ren, Qilin Chen, Hugang Jiang, Xinke Zhao, Kai Liu, Yingdong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.14373 |
Similar Items
-
Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity?
by: A. M. Chaulin, et al.
Published: (2023-05-01) -
Development and validation of a nomogram to predict cardiac death after radiotherapy for esophageal cancer
by: Xinfang Lv, et al.
Published: (2023-10-01) -
The Value of Troponin as a Biomarker of Chemotherapy-Induced Cardiotoxicity
by: Victorita Sorodoc, et al.
Published: (2022-08-01) -
Highly Sensitive Cardiac Troponins: The Evidence Behind Sex‐Specific Cutoffs
by: Prerana M. Bhatia, et al.
Published: (2020-05-01) -
Cardiac Biomarkers for the Detection and Management of Cancer Therapy-Related Cardiovascular Toxicity
by: Xinxin Zhang, et al.
Published: (2022-10-01)